Table 2_Efficacy and safety of transcutaneous electrical acupoint stimulation and acupress

Jiang Yuan published a dataset from a randomized clinical trial on 198 female breast cancer patients undergoing chemotherapy. The data, last updated in April 2026, compares the effects of transcutaneous electrical acupoint stimulation (TEAS) and acupressure against a control group over four chemotherapy cycles. It measures outcomes including nausea, vomiting, sleep quality, anxiety, depression, and quality of life.

Use Cases

• Modeling the dynamic effects of non-invasive interventions on chemotherapy-induced nausea and vomiting based on longitudinal follow-up data.
• Analyzing the relationship between intervention type and patient quality of life scores mentioned in the results.
• Comparing the efficacy of TEAS versus acupressure for alleviating psychological symptoms like anxiety and depression.
• Investigating time-interaction effects on sleep quality and delayed nausea across chemotherapy cycles.

Strengths

• Data from a randomized clinical trial with 198 participants.
• Longitudinal follow-up over four complete chemotherapy cycles.
• Analysis includes intention-to-treat and per-protocol set methods.

Limitations

• Row count and column-level documentation are unknown.
• The dataset is very small at 17.4 KB, indicating limited scope.
• Description metadata is limited; actual data quality requires manual inspection after download.

Provenance

Source

figshare, author Jiang Yuan.

Collection Method

Data gathered from a randomized clinical trial (ChiCTR2300077667) using simple randomization with R4.4.2.

Time Range

Covers four chemotherapy cycles for each participant.

Freshness

Last updated 2026-04-15 04:37:16; freshness should be verified.

Geography

Likely China, based on the clinical trial registry identifier.